semaglutide heart problems We've recommended (Wegovy) on the NHS to protect patients from a second heart attack or stroke. Here's what you need to know: https://www.nice.org.uk/news/articles/semaglutide-injection-to-help-prevent- heart-attacks-and-strokes STEP-HFpEF Trial

Risk of bias assessment Risk of bias assessment within studies was assessed for the primary outcome by two reviewers independently using the revised Cochrane Collaborations Risk of Bias Tool (ROB) version 2.0 [15]

Essentially, patients without diabetes demonstrate even higher discontinuation rates (64.8% at one year and 84.4% at two years) compared to those with diabetes (46.5% at one year and 64.1% at two years)

Patients often face a diagnostic delay of about 710 years from the onset of symptoms to an accurate diagnosis [9]

Potential Side Effects and Safety Considerations GLP-1 medications can cause side effects, and they are not appropriate for everyone

Expected change: ~58 kg total 36 Months: Sustained Results This is where long-term benefits become clear